The Arteriovenous Vascular (AV) ACCESS Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 103 participants.

Also called NCT04646226

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04646226
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04646226. Randomized; no masking; primary purpose treatment. Start 2022-08-18 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Arteriovenous Vascular (AV) ACCESS Trial
Condition
End-Stage Kidney Disease
Condition
Hemodialysis Complication
Intervention (Device)
AV graft
Intervention (Procedure)
surgical intervention for creation of a fistula
Lead sponsor
Wake Forest University Health Sciences (class: other)
Collaborator
National Institute on Aging (NIA) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct04646226
Content hash
2430ff8a83b00a68b912eac006b851d7c64fdfacab9cf3f60009e930a5f6d916